These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10449111)

  • 1. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.
    Soliveri P; Monza D; Paridi D; Radice D; Grisoli M; Testa D; Savoiardo M; Girotti F
    Neurology; 1999 Aug; 53(3):502-7. PubMed ID: 10449111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
    Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case manifested overlapping neuropathologic features of both progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)].
    Inagaki T; Seno HI; Iijima M; Nagai A; Bokura H; Kobayashi S; Wada M; Harada T
    No To Shinkei; 1998 Mar; 50(3):263-71. PubMed ID: 9566003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limb apraxia in corticobasal degeneration and progressive supranuclear palsy.
    Soliveri P; Piacentini S; Girotti F
    Neurology; 2005 Feb; 64(3):448-53. PubMed ID: 15699373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P; Sławek J; Derejko M; Dubaniewicz M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.
    Mimuro M; Yoshida M
    Neuropathology; 2020 Feb; 40(1):57-67. PubMed ID: 31515852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Illán-Gala I; Nigro S; VandeVrede L; Falgàs N; Heuer HW; Painous C; Compta Y; Martí MJ; Montal V; Pagonabarraga J; Kulisevsky J; Lleó A; Fortea J; Logroscino G; Quattrone A; Quattrone A; Perry DC; Gorno-Tempini ML; Rosen HJ; Grinberg LT; Spina S; La Joie R; Rabinovici GD; Miller BL; Rojas JC; Seeley WW; Boxer AL
    JAMA Netw Open; 2022 Apr; 5(4):e229588. PubMed ID: 35486397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
    Whitwell JL; Jack CR; Parisi JE; Gunter JL; Weigand SD; Boeve BF; Ahlskog JE; Petersen RC; Dickson DW; Josephs KA
    Eur J Neurol; 2013 Oct; 20(10):1417-22. PubMed ID: 23746093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxel-based morphometry in autopsy proven PSP and CBD.
    Josephs KA; Whitwell JL; Dickson DW; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Jack CR
    Neurobiol Aging; 2008 Feb; 29(2):280-9. PubMed ID: 17097770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration.
    Wakabayashi K; Takahashi H
    Neuropathology; 2004 Mar; 24(1):79-86. PubMed ID: 15068177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EEG findings in early-stage corticobasal degeneration and progressive supranuclear palsy: a retrospective study and literature review.
    Tashiro K; Ogata K; Goto Y; Taniwaki T; Okayama A; Kira J; Tobimatsu S
    Clin Neurophysiol; 2006 Oct; 117(10):2236-42. PubMed ID: 16920021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome.
    Chung EJ; Cho HJ; Jang W; Hur DY; Kim YS; Lee KH; Kim SJ
    J Korean Med Sci; 2022 Jun; 37(22):e183. PubMed ID: 35668689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cortical atrophy between progressive supranuclear palsy and corticobasal degeneration by hemispheric surface display of MR images.
    Taki M; Ishii K; Fukuda T; Kojima Y; Mori E
    AJNR Am J Neuroradiol; 2004; 25(10):1709-14. PubMed ID: 15569735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Hasebe S; Murayama S; Morimoto S; Kanemaru K; Takao M; Shibamoto Y; Matsukawa N
    Neuroimage Clin; 2015; 7():605-10. PubMed ID: 26082887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging-pathologic correlation in corticobasal degeneration.
    Tokumaru AM; Saito Y; Murayama S; Kazutomi K; Sakiyama Y; Toyoda M; Yamakawa M; Terada H
    AJNR Am J Neuroradiol; 2009 Nov; 30(10):1884-92. PubMed ID: 19833793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration.
    Schofield EC; Caine D; Kril JJ; Cordato NJ; Halliday GM
    Mov Disord; 2005 Jan; 20(1):34-9. PubMed ID: 15390131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential usefulness of signal intensity of cerebral gyri on quantitative susceptibility mapping for discriminating corticobasal degeneration from progressive supranuclear palsy and Parkinson's disease.
    Miyata M; Kakeda S; Toyoshima Y; Ide S; Okada K; Adachi H; Wang Y; Korogi Y
    Neuroradiology; 2019 Nov; 61(11):1251-1259. PubMed ID: 31267152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distal-proximal differences in limb apraxia in corticobasal degeneration but not progressive supranuclear palsy.
    Soliveri P; Piacentini S; Paridi D; Testa D; Carella F; Girotti F
    Neurol Sci; 2003 Oct; 24(3):213-4. PubMed ID: 14598093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.